Clinical Trial Update: Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether intraoperative dexmedetomidine affects the development of acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumor

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Malignant Tumor | Phase 4 | Status: COMPLETED